Page 106 - TD-3-4
P. 106

Tumor Discovery                                                   Bioinformatics insights into CCL2 mutations




                      Specificity  0.79  0.84  0.89  0.74  0.73  0.92  0.95  0.71  0.68  0.18  0.35  0.88  0.91  0.67  0.09  0.09  0.26  0.8  0.85  0.78  0.83  0.59  0.89  0.68  0.7  0.93  0.74  0.56  0.45  0.57  (Cont’d...)



                      Sensitivity  0.84  0.8  0.72  0.88  0.89  0.63  0.51  0.9  0.91  0.99  0.98  0.73  0.68  0.91  0.99  0.99  0.98  0.83  0.78  0.85  0.81  0.94  0.71  0.91  0.9  0.59  0.88  0.95  0.97  0.95



                   PolyPhen-2  Score  0.4  0.637  0.86  0.209  0.181  0.959  0.99  0.139  0.098  0.002  0.004  0.839  0.921  0.086  0.001  0.001  0.003  0.449  0.691  0.348  0.603  0.028  0.876  0.098  0.119  0.976  0.21  0.021  0.006  0.022





                      Analysis  Possibly damaging  Possibly damaging  Possibly damaging  Possibly damaging  Possibly damaging  Possibly damaging  Possibly damaging  Possibly damaging  Possibly damaging  Possibly damaging  Possibly damaging


                        Benign   Benign  Benign  Benign  Benign  Benign  Benign  Benign  Benign  Benign  Benign  Benign  Benign  Benign  Benign  Benign  Benign  Benign  Benign



                   Meta-SNP  Score  Analysis  0.248  Normal  0.128  Normal  0.085  Normal  0.082  Normal  0.071  Normal  0.422  Normal  0.383  Normal  0.075  Normal  0.074  Normal  0.076  Normal  0.089  Normal  0.498  Normal  0.653  Disease  0.096  Normal  0.293  Normal  0.056  Normal  0.167  Normal  0.136  Normal  0.609  Disease  0.302  Normal  0.249  Normal  0.092  Normal  0.484  Normal  0.304  Normal  0.314  Normal  0.795  Disease  0.25  Normal  0.145  Normal  0.244  N




                 Prediction of deleterious mutation  SNAP  Score  Analysis  0.25  Normal  0.15  0.34  Normal  0.41  0.275  Normal  0.42  0.095  Normal  0.44  0.13  Normal  0.27  0.46  Normal  0.01  0.485  Normal  0.11  0.175  Normal  0.42  0.145  Normal  0.48  0.16  Normal  0.44  0.145  Normal  0.38  0.585  Disease  0.08  0.62  Disease  0.08  0.13  Normal  0.55  0.37  Normal  0.31  0.19  Normal  0.41  0.245  Normal  0.76  0.32  Normal  0.35  0.55  Disease  0.47  0.37  Nor











                      Analysis SIFT   Score  Normal  Normal  Normal  Normal  Normal  Disease  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Disease  Normal  Normal  Normal  Normal
             Table 1. Harmful mutation predictions using in silico online tools


                   PhD-SNP   Score  0.153  0.12  0.075  0.05  0.033  0.242  0.208  0.037  0.047  0.05  0.082  0.571  0.749  0.103  0.346  0.088  0.134  0.123  0.498  0.369  0.213  0.081  0.324  0.425  0.355  0.717  0.2  0.18  0.229  0.384

                      Analysis  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Disease  Disease  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Disease  Normal  Normal  Normal  Normal



                      Score  0.982  0.466  0.567  0.255  0.196  0.696  0.871  0.266  0.269  0.169  0.127  0.482  0.727  0.122  0.119  0.285  0.148  0.262  0.351  0.374  0.384  0.183  0.619  0.286  0.274  0.903  0.19  0.222  0.178  0.226
                   Panther
                      Analysis  Disease  Normal  Disease  Normal  Normal  Disease  Disease  Normal  Normal  Normal  Normal  Normal  Disease  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Normal  Disease  Normal  Normal  Disease  Normal  Normal  Normal  Normal


                    Mutants  M1L  K2E  K2T  K2R  V3I  V3G  S4F  A5V  A5T  I13T  I13V  A14E  A15P  T16S  I18N  I18T  P19L  P19Q  Q20R  A23T  A23S  A27G  A27V  N29K  P31A  Y36C  N37D  T39I  T39A  N40D



                    Serial number  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30







            Volume 3 Issue 4 (2024)                         8                                 doi: 10.36922/td.3891
   101   102   103   104   105   106   107   108   109   110   111